Članki z zahtevami za javni dostop - Elizabeth MillerVeč o tem
Ni na voljo nikjer: 3
Durability of the neutralizing antibody response to vaccine and non-vaccine HPV types 7 years following immunization with either Cervarix® or Gardasil® vaccine
A Godi, K Panwar, M Haque, CE Cocuzza, N Andrews, J Southern, ...
Vaccine 37 (18), 2455-2462, 2019
Zahteve: National Institute for Health Research, UK
Responses to live attenuated influenza vaccine in children vaccinated previously with Pandemrix (ASO3B adjuvanted pandemic A/H1N1pdm09)
K Höschler, J Southern, C Thompson, F Warburton, NJ Andrews, E Miller, ...
Vaccine 36 (21), 3034-3040, 2018
Zahteve: National Institute for Health Research, UK
Extensive swelling of the limb and systemic symptoms after a fourth dose of acellular pertussis containing vaccines in England in children aged 3–6 years
J Southern, PA Waight, N Andrews, E Miller
Vaccine 35 (4), 619-625, 2017
Zahteve: National Institute for Health Research, UK
Na voljo nekje: 67
Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study
NJ Andrews, PA Waight, P Burbidge, E Pearce, L Roalfe, M Zancolli, ...
The Lancet infectious diseases 14 (9), 839-846, 2014
Zahteve: National Institute for Health Research, UK
Assessing optimal target populations for influenza vaccination programmes: an evidence synthesis and modelling study
M Baguelin, S Flasche, A Camacho, N Demiris, E Miller, WJ Edmunds
PLoS medicine 10 (10), e1001527, 2013
Zahteve: UK Medical Research Council
Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines
S Black, J Eskola, CA Siegrist, N Halsey, N MacDonald, B Law, E Miller, ...
The Lancet 374 (9707), 2115-2122, 2009
Zahteve: US National Institutes of Health
Sustained effectiveness of the maternal pertussis immunization program in England 3 years following introduction
G Amirthalingam, H Campbell, S Ribeiro, NK Fry, M Ramsay, E Miller, ...
Clinical Infectious Diseases 63 (suppl_4), S236-S243, 2016
Zahteve: Bill & Melinda Gates Foundation
Generation time of the alpha and delta SARS-CoV-2 variants: an epidemiological analysis
WS Hart, E Miller, NJ Andrews, P Waight, PK Maini, S Funk, ...
The Lancet Infectious Diseases 22 (5), 603-610, 2022
Zahteve: UK Engineering and Physical Sciences Research Council, National Institute …
Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a …
SN Ladhani, NJ Andrews, J Southern, CE Jones, G Amirthalingam, ...
Clinical infectious diseases 61 (11), 1637-1644, 2015
Zahteve: National Institute for Health Research, UK
A randomized, observer-blinded immunogenicity trial of Cervarix® and Gardasil® human papillomavirus vaccines in 12-15 year old girls
E Draper, SL Bissett, R Howell-Jones, P Waight, K Soldan, M Jit, ...
PloS one 8 (5), e61825, 2013
Zahteve: UK Medical Research Council
Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1+ 1) compared with two primary doses and a booster (2+ 1) in UK infants: a multicentre …
D Goldblatt, J Southern, NJ Andrews, P Burbidge, J Partington, L Roalfe, ...
The Lancet Infectious Diseases 18 (2), 171-179, 2018
Zahteve: Bill & Melinda Gates Foundation, National Institute for Health Research, UK
Pneumococcal carriage in children and their household contacts six years after introduction of the 13-valent pneumococcal conjugate vaccine in England
J Southern, N Andrews, P Sandu, CL Sheppard, PA Waight, NK Fry, ...
PLoS One 13 (5), e0195799, 2018
Zahteve: National Institute for Health Research, UK
Safety of live attenuated influenza vaccine in atopic children with egg allergy
PJ Turner, J Southern, NJ Andrews, E Miller, M Erlewyn-Lajeunesse, ...
Journal of Allergy and Clinical Immunology 136 (2), 376-381, 2015
Zahteve: UK Medical Research Council, National Institute for Health Research, UK
Impact of outpatient neuraminidase inhibitor treatment in patients infected with influenza A (H1N1) pdm09 at high risk of hospitalization: an individual participant data …
S Venkatesan, PR Myles, J Leonardi-Bee, SG Muthuri, M Al Masri, ...
Clinical Infectious Diseases 64 (10), 1328-1334, 2017
Zahteve: Canadian Institutes of Health Research, UK Medical Research Council
Elucidating the impact of the pneumococcal conjugate vaccine programme on pneumonia, sepsis and otitis media hospital admissions in England using a composite control
D Thorrington, N Andrews, J Stowe, E Miller, AJ Van Hoek
BMC medicine 16, 1-14, 2018
Zahteve: National Institute for Health Research, UK, European Commission
Safety of live attenuated influenza vaccine in young people with egg allergy: multicentre prospective cohort study
PJ Turner, J Southern, NJ Andrews, E Miller, M Erlewyn-Lajeunesse
Bmj 351, 2015
Zahteve: UK Medical Research Council, National Institute for Health Research, UK
Seroprevalence of antibodies against serogroup C meningococci in England in the postvaccination era
CL Trotter, R Borrow, J Findlow, A Holland, S Frankland, NJ Andrews, ...
Clinical and vaccine immunology 15 (11), 1694-1698, 2008
Zahteve: US National Institutes of Health
The potential for reducing the number of pneumococcal conjugate vaccine doses while sustaining herd immunity in high-income countries
S Flasche, AJ Van Hoek, D Goldblatt, WJ Edmunds, KL O’Brien, JAG Scott, ...
PLoS medicine 12 (6), e1001839, 2015
Zahteve: Bill & Melinda Gates Foundation, US National Institutes of Health, National …
Inference of the SARS-CoV-2 generation time using UK household data
WS Hart, S Abbott, A Endo, J Hellewell, E Miller, N Andrews, PK Maini, ...
Elife 11, e70767, 2022
Zahteve: UK Engineering and Physical Sciences Research Council, National Institute …
Cost-effectiveness of vaccinating immunocompetent≥ 65 year olds with the 13-valent pneumococcal conjugate vaccine in England
AJ Van Hoek, E Miller
PloS one 11 (2), e0149540, 2016
Zahteve: National Institute for Health Research, UK
Podatke o objavi in financiranju samodejno določi računalniški program